[go: up one dir, main page]

AR105504A1 - Concentrado que contiene alprostadil - Google Patents

Concentrado que contiene alprostadil

Info

Publication number
AR105504A1
AR105504A1 ARP160102285A ARP160102285A AR105504A1 AR 105504 A1 AR105504 A1 AR 105504A1 AR P160102285 A ARP160102285 A AR P160102285A AR P160102285 A ARP160102285 A AR P160102285A AR 105504 A1 AR105504 A1 AR 105504A1
Authority
AR
Argentina
Prior art keywords
solvent mixture
concentrate containing
acid
containing alprostadil
water
Prior art date
Application number
ARP160102285A
Other languages
English (en)
Inventor
Husler Franz
Hansbauer Bernhard
Hesse Ernst
Original Assignee
Gebro Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gebro Holding Gmbh filed Critical Gebro Holding Gmbh
Publication of AR105504A1 publication Critical patent/AR105504A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica líquida en forma de un concentrado para la preparación de una solución para infusión, que contiene alprostadil (prostaglandina E1) como principio activo, disuelto en una mezcla de disolventes de al menos un disolvente orgánico farmacéuticamente aceptable y agua, y se caracteriza por que la proporción de agua total en la mezcla de disolventes se encuentra en el intervalo del 8 al 85% en peso de H₂O, referido a la cantidad total de la mezcla de disolventes, y por que al menos un ácido o una sustancia que actúa de ácido o de donador de protones está contenida como estabilizador para el principio activo.
ARP160102285A 2015-07-27 2016-07-27 Concentrado que contiene alprostadil AR105504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ATA50666/2015A AT518009A1 (de) 2015-07-27 2015-07-27 Konzentrat enthaltend Alprostadil

Publications (1)

Publication Number Publication Date
AR105504A1 true AR105504A1 (es) 2017-10-11

Family

ID=56852017

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102285A AR105504A1 (es) 2015-07-27 2016-07-27 Concentrado que contiene alprostadil

Country Status (8)

Country Link
EP (1) EP3328358B1 (es)
AR (1) AR105504A1 (es)
AT (1) AT518009A1 (es)
BR (1) BR112018001637A2 (es)
CO (1) CO2018000525A2 (es)
MX (1) MX2018001042A (es)
PE (1) PE20180466A1 (es)
WO (1) WO2017015692A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
DE4342232A1 (de) * 1993-12-10 1995-06-14 Hexal Pharma Gmbh Feste Zubereitung für therapeutische Zwecke mit einem Gehalt an Prostaglandin E1
CN102048687A (zh) * 2009-11-06 2011-05-11 华北制药集团制剂有限公司 一种前列地尔注射液的制备方法
CN103110579B (zh) * 2013-02-20 2014-12-10 北京德立福瑞医药科技有限公司 前列地尔注射剂

Also Published As

Publication number Publication date
EP3328358A1 (de) 2018-06-06
PE20180466A1 (es) 2018-03-06
WO2017015692A1 (de) 2017-02-02
AT518009A1 (de) 2017-06-15
MX2018001042A (es) 2018-06-07
BR112018001637A2 (pt) 2018-09-18
CO2018000525A2 (es) 2018-04-10
EP3328358B1 (de) 2022-11-23

Similar Documents

Publication Publication Date Title
MX2018003096A (es) Composicion farmaceutica que contiene farmaco anionico, y metodo de preparacion para la misma.
PE20160681A1 (es) Formulacion de premezcla de dexmedetomidina
MX2016006641A (es) Composición novedosa y método de uso para controlar patógenos y prevenir enfermedades en semillas.
BR112015025172A2 (pt) composição farmacêutica
CO7111300A2 (es) Formulación de anticuerpos
AR088381A1 (es) Formulaciones de etanercept estabilizadas con meglumina
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
NI201500167A (es) Compuestos químicos
DOP2015000170A (es) Compuestos químicos
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
MX2019003520A (es) Mezclas y formulacions que comprenden una sal de alquil amonio de acido etilendiaminotetraacetico (edta).
PE20150226A1 (es) Agentes terapeuticos para administracion subcutanea optimizados
BR112016022394A2 (pt) Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável
DOP2016000007A (es) Pirazolpiridinas sustituidas
AR096338A1 (es) (ciano-dimetil-metil)-isoxazoles y -[1,3,4]tiadiazoles
BR112016015190A8 (pt) Composição farmacêutica livre de antioxidante e método de preparação da mesma
BR112015022290A2 (pt) derivados de heterocíclicos benzo-fundidos úteis como agonistas de gpr120
AR105504A1 (es) Concentrado que contiene alprostadil
AR090959A1 (es) Analogos de hexadepsipeptidos como compuestos anticancerigenos
CY1122694T1 (el) Φαρμακοτεχνικη μορφη η οποια περιεχει κουρκουμινη
CO2018000526A2 (es) Concentrado que contiene alprostadil
MX342069B (es) Formulaciones farmacéuticas que comprenden un fosfolípido como mejorador de la penetración de un principio activo en la piel.
MX2016009458A (es) Solucion alcoholica estable de alprostadilo.
BR112015023750A2 (pt) composição agricolamente ativa concentrada; método de preparação da composição pronta para uso; composição pronta para uso; e método para o tratamento de uma planta
AR100850A1 (es) Composición farmacéutica que comprende desmopresina y un agente estabilizador

Legal Events

Date Code Title Description
FC Refusal